Bandingkan Harga & Kinerja Mitrabara Adiperdana Tbk. (MBAP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mitrabara Adiperdana Tbk. dan Organon Pharma Indonesia Tbk.: Mitrabara Adiperdana Tbk. diperdagangkan di Rp1.720 (kapitalisasi pasar 2,16 T, volume 24 jam 52 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mitrabara Adiperdana Tbk. jauh lebih besar — sekitar 20,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MBAP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,16 T | 104,4 M |
Volume | 52 rb | — |
Lot | 520 | — |
Perputaran | 89 jt | — |
Harga Rata-rata | 1.711,52 | — |
Nilai Transaksi | 89 jt | — |
Harga Ekuilibrium Indikatif | 1.720 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mitrabara Adiperdana Tbk.
PT Mitrabara Adiperdana Tbk (the Company) was established in the Republic of Indonesia under its initial name of PT Mitrabara Adiperdana on May 29, 1992 based on the Notarial Deed No. 34 of H.A. Kadir Usman, S.H.
Selengkapnya di halaman MBAP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
